Caplin Point Laboratories Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹961.8
- Today's High:
- ₹1048
- Open Price:
- ₹1040
- 52W Low:
- ₹573.5782
- 52W High:
- ₹1098.9
- Prev. Close:
- ₹1037.55
- Volume:
- 58816
Company Statistics
- Market Cap.:
- ₹40.04 billion
- Book Value:
- 139.566
- Revenue TTM:
- ₹9.52 billion
- Operating Margin TTM:
- 25.9%
- Gross Profit TTM:
- ₹4.43 billion
- Profit Margin:
- 22.98%
- Return on Assets TTM:
- 14.02%
- Return on Equity TTM:
- 24.38%
Company Profile
Caplin Point Laboratories Limited had its IPO on under the ticker symbol 524742.
The company operates in the Other sector and Other industry. Caplin Point Laboratories Limited has a staff strength of 1,696 employees.
Stock update
Shares of Caplin Point Laboratories Limited opened at ₹1040 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹961.8 - ₹1048, and closed at ₹972.85.
This is a -6.24% slip from the previous day's closing price.
A total volume of 58,816 shares were traded at the close of the day’s session.
In the last one week, shares of Caplin Point Laboratories Limited have slipped by -9.1%.
Caplin Point Laboratories Limited's Key Ratios
Caplin Point Laboratories Limited has a market cap of ₹40.04 billion, indicating a price to book ratio of 3.4754 and a price to sales ratio of 3.8858.
In the last 12-months Caplin Point Laboratories Limited’s revenue was ₹9.52 billion with a gross profit of ₹4.43 billion and an EBITDA of ₹2.80 billion. The EBITDA ratio measures Caplin Point Laboratories Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Caplin Point Laboratories Limited’s operating margin was 25.9% while its return on assets stood at 14.02% with a return of equity of 24.38%.
In Q3, Caplin Point Laboratories Limited’s quarterly earnings growth was a negative -0.7% while revenue growth was a positive 18%.
Caplin Point Laboratories Limited’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 16.8966
- PEG
Its diluted EPS in the last 12-months stands at ₹28.71 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Caplin Point Laboratories Limited’s profitability.
Caplin Point Laboratories Limited stock is trading at a EV to sales ratio of 3.4133 and a EV to EBITDA ratio of 10.1885. Its price to sales ratio in the trailing 12-months stood at 3.8858.
Caplin Point Laboratories Limited stock pays annual dividends of ₹2.5 per share, indicating a yield of 0.52% and a payout ratio of 8.71%.
Balance sheet and cash flow metrics
- Total Assets
- ₹21.91 billion
- Total Liabilities
- ₹2.68 billion
- Operating Cash Flow
- ₹-2178600000.00
- Capital Expenditure
- ₹1.94 billion
- Dividend Payout Ratio
- 8.71%
Caplin Point Laboratories Limited ended 2024 with ₹21.91 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹21.91 billion while shareholder equity stood at ₹18.80 billion.
Caplin Point Laboratories Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹2.68 billion in other current liabilities, 151800000.00 in common stock, ₹17.91 billion in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹0 and cash and short-term investments were ₹7.25 billion. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.
Caplin Point Laboratories Limited’s total current assets stands at ₹15.54 billion while long-term investments were ₹0 and short-term investments were ₹2.31 billion. Its net receivables were ₹3.94 billion compared to accounts payable of ₹0 and inventory worth ₹2.88 billion.
In 2024, Caplin Point Laboratories Limited's operating cash flow was ₹-2178600000.00 while its capital expenditure stood at ₹1.94 billion.
Comparatively, Caplin Point Laboratories Limited paid ₹0.09 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹972.85
- 52-Week High
- ₹1098.9
- 52-Week Low
- ₹573.5782
- Analyst Target Price
- ₹
Caplin Point Laboratories Limited stock is currently trading at ₹972.85 per share. It touched a 52-week high of ₹1098.9 and a 52-week low of ₹1098.9. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹950.4 and 200-day moving average was ₹764.92 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 7553.9% of the company’s stock are held by insiders while 206.6% are held by institutions.
Frequently Asked Questions About Caplin Point Laboratories Limited
Similar Industry Stocks (Other)
Most Active
Top Gainers
Top Losers
About
Caplin Point Laboratories Limited develops, manufactures, markets, and exports generic pharmaceutical formulations and branded generic products in India and internationally. It provides tablets, capsules, vials, ophthalmic products, liquid orals, soft gel capsules, ointments, creams and gels, powder for injections, suppositories and ovules, dermo cosmetics, surgicals and disposables, pre-mix bag formulations, inhalers and sprays, IV infusion products, dry syrups, topicals, and other products, as well as liquid, lyophilized, and pre-filled injection syringes. The company also operates QueTenX, an e-commerce website. Caplin Point Laboratories Limited was founded in 1990 and is based in Chennai, India.